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A new flavor in phosphotyrosine recognition
The phosphotyrosine-binding (PTB) domain, recently identified in a number
of proteins, specifically recognizes tyrosine-phosphorylated sequences
in other proteins. Although similar in function to the well-studied
SH2 domain, the PTB domain appears to be structurally unrelated.
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Elucidation of the cytoplasmic signalling pathways stimu-
lated by activation of cell-surface receptors has high-
lighted the importance of several modular protein
domains that direct the flow of information from the
membrane to the nucleus. Src homology 3 (SH3) and Src
homology 2 (SH2) domains, found in a wide variety of
signalling proteins, were first recognized in the non-cat-
alytic region of Src-family tyrosine kinases. They mediate
defined inter- and intra-molecular interactions and
thereby regulate the cellular localization and activity of
their associated catalytic domains. The SH2 domain,
which comprises about 100 amino acids, binds sequences
phosphorylated on tyrosine. The SH3 domain, a com-
pact 13-sandwich of about 60 amino acids, binds to pro-
line-rich sequences in target proteins. A third modular
domain, the pleckstrin homology (PH) domain, is also
found in many signalling and cytoskeletal proteins, but its
precise function in signal transduction is unclear. The
structure and function of SH2, SH3 and P- domains
have been reviewed extensively [1-4].
Because of its central role in phosphotyrosine-mediated
signalling, the SH2 domain has held center stage in the
unfolding signal transduction drama. But it must now
.share the spotlight with a fourth modular signalling motif,
dubbed the PTB domain for its phosphotyrosine-binding
function [5]. This new phosphotyrosine-binding element
has been identified in the N-terminal region of Shc
[5-7], an SH2-containing protein that couples growth
factor receptor signalling to the Ras activation pathway
[8]. The PTB domain appears to recognize the sequence
motif NPXpY (where X is any amino acid and pY is
phosphotyrosine), which is found in a number of acti-
vated growth factor receptors. The multitude of potential
binding sites for the PTB domain, and its identification
by sequence homology in other signalling proteins [9],
suggest that it may have broad significance in signal
transduction, akin to SH3 and SH2 domains.
Shc in signalling
The domain structure of Shc includes the N-terminal
PTB domain, a central region with a tyrosine phos-
phorylation site and sequence similarity to a-i collagen,
and a C-terminal SH2 domain [8]. Figure 1 illustrates the
role of Shc in mitogenic signalling ([10,11], and see [4]
for review). Activation of growth factor receptors, such as
the epidermal growth factor (EGF) receptor, induces
receptor dimerization and 'cross-autophosphorylation' of
the cytoplasmic tyrosine kinase domains. These phos-
phorylated tyrosines, found largely in regions outside the
kinase domain, have been known to serve as docking
sites for SH2 proteins. Phospholipase C-y, p120-GAP,
Fig. 1. The function of Shc in growth
factor receptor signalling via Ras.
Shc (yellow) has both an SH2 and a
PTB domain with which it may bind
activated growth factor receptors.
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and phosphatidylinositol 3'-kinase are among the proteins
recruited to activated EGF receptors. Grb2, an 'adaptor'
molecule composed of an SH2 domain flanked by SH3
domains, also binds the phosphorylated EGF receptor,
carrying with it the guanine nucleotide exchange pro-
tein, Sos, with which it associates via its SH3 domains.
This series of interactions brings Sos to the membrane,
where it can activate Ras. The Grb2-SOS complex can
also bind the EGF receptor indirectly using phosphory-
lated Shc as an intermediate [11]. The role of Shc as an
adaptor protein in this and other pathways seemed rea-
sonable at the time of its discovery, because it contained
both an SH2 domain, with which it was assumed to bind
the activated receptor, and a tyrosine phosphorylation site
bearing a sequence known to be recognized by the Grb2
SH2 domain. One puzzling detail, however, was the
observation that many of the sequences recognized by
Shc were only homologous in the region N-terminal to
the phosphorylated tyrosine (Fig. 2), unlike any known
SH2-binding sites, which include residues C-terminal to
the phosphotyrosine. Comparison of Shc-binding sites in
polyoma middle T antigen, Trk (the receptor for nerve
growth factor), the EGF receptor, and ErbB-2 revealed
that they have an NPXpY motif in common. Evidence
that Shc binds this motif in polyoma middle T antigen is
particularly strong; mutation of a single NPXpY site
almost completely abolishes both its Shc binding and cell
transforming ability [12].
Enter the PTB domain. Kavanaugh and Williams [5],
Blaikie et al. [6], and van der Geer et al. [7] have now
shown that the previously innominate N-terminal region
of Shc can bind specifically to tyrosine-phosphorylated
proteins, including the activated EGF receptor. The min-
imal fragment of Shc that showed binding activity as a
glutathione S transferase (GST)-fusion protein spanned
residues 46-209 [5]. Residue 46 corresponds to an alter-
native translation initiation site for a 46 kDa isoform of
Shc. Human, murine, and Drosophila Shc, as well as a
recently cloned Shc-like protein called SCK, show a high
degree of sequence homology in this region (Fig. 3).
Fig. 2. Shc-binding sites in polyoma middle T antigen (MT) and
growth factor receptors. The region known to be important for
recognition by the PTB of Shc is highlighted and includes the
NPXpY motif. Shc is known to bind ErbB-3 [18], Trk [7,19],
polyoma middle T antigen [7,12,20], Neu [61, and the EGF
receptor [6,7,1 3].
Van der Geer et al. [7] show that an NPXpY-containing
peptide modeled on the polyoma middle T antigen site
(LLSNPTpYSVMRSK) competes with the activated
EGF receptor for binding to the Shc PTB domain. Effi-
cient competition requires a phosphorylated tyrosine and
at least five residues preceding it - truncated peptides
lacking the leucine at residue -5 (from pY) did not com-
pete. The Shc PTB also binds the Trk NPXpY site [7],
and the activated HER2/neu receptor [6], suggesting a
more general role for the domain in tyrosine kinase sig-
nalling pathways. The fact that the isolated Shc SH2
domain has also been shown to bind activated growth
factor receptors [13] suggests that the SH2 and PTB
domains may cooperate in receptor recognition, simul-
taneously binding sites in the same receptor. Alterna-
tively, the SH2 domain may recruit yet another protein
to the signalling complex. The physiologic role of the
PTB domain requires further study.
Not just another SH2 domain
In spite of their functional similarity, PTB domains seem
likely to be unrelated to SH2 domains. The core of the
PTB domain is about 160 amino acids and, overall, bears
no convincing sequence similarity to the 100-residue
SH2 domain. Although a region near the N terminus of
the PTB domain bears the sequence YLVR, which is
reminiscent of the conserved FLVRES sequence of SH2
domains [14], this is probably coincidental. The arginine
in the FLVRES motif is conserved in all SH2 domains;
crystal structures of SH2-ligand complexes demonstrate
that this residue binds directly to the phosphate oxygens
on the phosphotyrosine residue [15]. Mutation of the
arginine in the YLVR region of the PTB domain to
leucine, however, does not diminish the binding function
of the domain, arguing against any functional relationship
to the SH2 domain sequence [5].
Techniques developed to probe the binding specificity of
SH2 domains are likely to be rapidly applied to the PTB
domain. Already, binding assays with synthetic phospho-
peptides have revealed that the Shc PTB domain indeed
requires only residues N-terminal to the phosphotyrosine
- peptides with the phosphotyrosine at the C-terminus
bind equally well as longer motifs (S Shoelson, personal
communication). The region N-terminal to the phos-
photyrosine that can affect binding appears to extend at
least to the -5 position. A hydrophobic residue (usually
leucine) is found at the -5 position in most Shc-binding
sites (Fig. 2). Competition assays probing the affinity of
the Shc PTB for extended NPXpY phosphopeptide
motifs show half-maximal binding with concentrations
of phosphopeptide in the 1 M range, comparable to
SH2-phosphopeptide interactions. And, as with SH2
domains, non-phosphorylated peptides do not compete
(S Shoelson, personal communication).
Combinatorial peptide library screens have played a key
role in defining the varying specificities of SH2 domains.
Preliminary peptide library binding experiments with the
Shc PTB domain reiterate the preference for the NPXpY
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Fig. 3. Aligned sequences of the N-ter-
minal region of human [8], murine, and
Drosophila Shc 7] and the Shc-like pro-
tein SCK [5]. Numbering is according to
the human Shc sequence. An Shc frag-
ment spanning residues 46-209 has
been demonstrated to have phospho-
tyrosine-binding activity; this segment is
shaded. Human and murine Shc are
produced as both 52 kDa and 46 kDa
isoforms from the alternative translation
initiation sites of residues 1 and 46,
respectively.
motif, although these results must be interpreted
cautiously because the phosphopeptide library employed
was degenerate only at positions -1 to -3 (Z Songyang,
personal communication).
Computer searches of sequence databases have revealed
several additional proteins that contain this binding motif:
Bork and Margolis find seven sequences in addition to
Shc and SCK that encode the domain [9], including
Disabled, a Drosophila protein known to be tyrosine
phosphorylated [16]. Though phosphotyrosine-binding
activity has yet to be demonstrated in this larger set of
similar domains, the extent of sequence conservation is
consistent with a conserved function for the domain in
phosphotyrosine signalling. Bork and Margolis found no
PTB homologs in prokaryotes or yeast, which lack
protein tyrosine kinases.
In SH2 domains, highly conserved basic residues are
crucial for phosphotyrosine binding. In addition to the
arginine of FLVRES described above, a second arginine
that is conserved in most SH2 domains makes an
'amino-aromatic' interaction with the phosphotyrosyl
ring and hydrogen bonds to a phosphate oxygen. The
Shc PTB domain is quite basic, with a calculated p of
-10. Alignment of the closely related Shc and SCK
sequences shows many conserved basic residues, but
alignments that include more distant relatives do not
reveal any highly conserved basic residues that might be
the functional counterparts of the conserved arginines in
SH2 domains. This may, however, be a consequence of
the difficulty in accurately aligning more distantly related
sequences.
Much of the richness in SH2 biology stems from the
divergent binding specificities that have evolved for the
conserved core domain, enabling its use in many sig-
nalling pathways. It remains to be demonstrated whether
PTB domains vary in their specificity, and to what extent
such specificity is exploited in signal transduction. But
clearly this newly identified domain could greatly expand
the repertoire of interactions regulated by tyrosine phos-
phorylation. Are there more phosphotyrosine recognition
domains awaiting discovery? A region just C-terminal to
the PH domain in the insulin receptor substrate (IRS-1)
appears to bind NPXpY motifs, but its sequence does not
suggest that it is a member of the PTB or SH2 domain
families [17]. Structural analysis of these newly defined
domains will aid in defining what, if any, evolutionary
relationships exist among them.
Indeed, the PTB domain and its interactions with
NPXpY ligands is an attractive subject for structural
study. The domain is likely to reveal an entirely new
mode of phosphopeptide recognition. And we should
not have long to wait - structural analysis of SH2, SH3
and PH domains has proceeded in pace with other bio-
chemical, genetic, and cellular investigations of these
domains, greatly enriching our understanding of the
molecular interactions that constitute signal transduction.
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